公司資料
Nutriband 股價、新聞與催化劑
- 股票代碼:
- NTRB
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.23 USD (-2.12%)
收盤價
最後更新: 2026年8月17日
43.2M USD
市值
股價為何變動
As of Aug 17, 2026, NTRB closed down 2.12% at $3.23. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Nutriband is a specialty drug-delivery company focused on transdermal technologies and abuse-deterrent patch platforms. Its story is centered on formulation science and the possibility of licensing or commercializing delivery systems for regulated products.
所在地與產業分類
Nutriband is headquartered in the United States and listed on NASDAQ, with a small-cap specialty drug-delivery profile. It sits in the pharmaceutical technology niche rather than broad biotech.
商業模式特徵
The business depends on product development, regulatory progress, and partner interest in the delivery platform. Investors typically watch licensing, formulation updates, and the company's ability to create value from a narrow technology base.
生技產業定位
Nutriband occupies a niche position in drug delivery and abuse-deterrent formulation. It is more of a platform story than a classic therapeutics stock.
未來催化劑
- Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible. The company still needs a practical commercialization path.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。